MATTHEW DOHLMAN: Open Payments
NPI 1245262419 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,128 in 257 payments from 19 companies in 2025. Trend: 2023 $7,807 · 2024 $10,347 · 2025 $9,128
Food & beverage: $4,591Speaker / faculty: $4,400Education: $76Travel & lodging: $62
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $4,935 |
| PFIZER INC. | 30 | $646 |
| Novartis Pharmaceuticals Corporation | 23 | $486 |
| Janssen Biotech, Inc. | 20 | $434 |
| Amgen Inc. | 19 | $413 |
| Arcutis Biotherapeutics, Inc. | 23 | $371 |
| UCB, Inc. | 31 | $298 |
| Regeneron Healthcare Solutions, Inc. | 11 | $296 |
| E.R. Squibb & Sons, L.L.C. | 18 | $255 |
| Lilly USA, LLC | 13 | $235 |
Products named: RINVOQ, SKYRIZI, CIBINQO, TREMFYA, OTEZLA, Zoryve, DUPIXENT, COSENTYX.
Industry payments across OK — which companies pay providers there.
